Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;17(1):52-57.
doi: 10.2174/1871529X16666161220142020.

Guide of Hypertensive Crisis Pharmacotherapy

Affiliations
Review

Guide of Hypertensive Crisis Pharmacotherapy

Priyanka Wani-Parekh et al. Cardiovasc Hematol Disord Drug Targets. .

Abstract

Background: Cardiovascular diseases (CVD) are the number one cause of death globally compared to any other cause. CVD accounts for approximately 17.3 million deaths per year and are rising. Hypertension is the leading risk factor for cardiovascular diseases. Approximately, 80 million people suffer from hypertension in the U.S. While, majority of these individuals are on antihypertensive medications only 54% of individuals with hypertension are optimally controlled. Heart failure and stroke are some of the devastating complications of uncontrolled hypertension. Hypertensive crisis can be classified as either an urgency or emergency; difference between the two is the presence of end organ damage, which is noted in hypertensive emergency. Hypertensive crisis is usually treated by parenteral antihypertensive medications. The main drug classes of drugs for treatment are nitrates, calcium channel blockers, dopamine-1 agonists, adrenergic-blocking agents etc.

Conclusion: In this review, we discuss approach to management of hypertensive crisis and each drug class with its physiology and complications.

Keywords: Hypertensive emergency; antihypertensive medications; cardiovascular disease; eclampsia; pregnancy.

Similar articles

See all similar articles

MeSH terms

Feedback